Trial Site Detail
Drug: |
NN3201 |
|||
|---|---|---|---|---|
Trial: |
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Recruiting |
|||
OHSU Knight Cancer Institute South Waterfront3485 S. Bond Avenue |
Principal Investigator: |
Michael Heinrich, MD |
|---|---|
Contact: |
Michael Heinrich, MD 503-220-3405 heinrich@ohsu.edu |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
OHSU Knight Cancer Institute South Waterfront Website: |
https://cancertrials.ohsu.edu/studies/?term~sc_paths=cancer-types_gastrointestinal-stromal-tumors |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.